DOCSLIB.ORG

1 Appendix Table 1. 25 Conflict-Affected Countries Involved

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
1 Appendix Table 1. 25 Conflict-Affected Countries Involved Supplementary material BMJ Global Health Appendix Table 1. 25 conflict-affected countries involved in the study Sub-Saharan Income classification WHO region Country African country in 20171 Africa Angola Yes UM Africa Burundi Yes L Africa Central African Republic Yes L Africa Chad Yes L Democratic Republic of the Africa Congo Yes L Africa Eritrea Yes L Africa Liberia Yes L Africa Nigeria Yes LM Africa Sierra Leone Yes L Africa Somalia Yes L Africa South Sudan Yes L Africa Sudan Yes LM Africa Uganda Yes L Americas Colombia No UM Europe Ukraine No LM Eastern Mediterranean Afghanistan No L Eastern Mediterranean Iraq No UM Eastern Mediterranean Libya No UM Eastern Mediterranean Pakistan No LM Eastern Mediterranean Syrian Arab Republic No LM Eastern Mediterranean Yemen No LM South-East Asia Myanmar No LM South-East Asia Nepal No L South-East Asia Sri Lanka No LM South-East Asia Timor-Leste No LM Note: 1. “L” represents “Low-income country”, “LM” represents “Lower-middle income country”, “UM” represents “Upper-middle income country”. 1 Li Z, et al. BMJ Global Health 2019; 4:e001614. doi: 10.1136/bmjgh-2019-001614 Supplementary material BMJ Global Health Appendix Table 2. List of donor countries included in the analysis DAC members Non-DAC multilateral donors Non-DAC donors Private donors 2014-2015, Bill & Melinda Australia 2003-2017 Adaptation fund 2011-2014, 2016 Azerbaijan 2017 Gates Foundation 2009-2017 Austria 2003-2017 African Development Bank 2003-2017 Bulgaria 2015-2017 Belgium 2003-2017 African Development Fund 2003-2017 Cyprus 2014-2015 Arab Bank for Economic Development Canada 2003-2017 in Africa 2011-2015 Estonia 2013-2017 Czech Republic 2011-2017 Arab Fund (AFESD) 2008-2017 Israel 2015-2016 2013-2015, Denmark 2003-2017 AsDB Special Funds 2003-2016 Kazakhstan 2017 EU Institutions 2003-2017 Asian Development Bank(AsDB) 2003-2017 Kuwait (KFAED) 2010-2017 Finland 2003-2017 Council of Europe Development Bank 2010-2015 Latvia 2015-2017 France 2003-2017 Climate Investment Funds 2012-2017 Lithuania 2014-2017 European Bank for Reconstruction and Germany 2003-2017 Development 2009-2017 Malta 2015-2017 Greece 2003-2017 Food and Agriculture Organization 2013 Romania 2014-2017 Global Alliance for Vaccines and Hungary 2014-2017 Immunisation 2003-2017 Russia 2015-2017 Iceland 2011-2017 Global Environment Facility 2003-2017 Thailand 2015-2017 Global Fund to Fight AIDS, Ireland 2003-2017 Tuberculosis and Malaria 2003-2017 Turkey 2015-2017 United Arab Italy 2003-2017 Global Green Growth Institute 2013-2017 Emirates 2009-2017 Japan 2003-2017 Green Climate Fund 2016-2017 2003, 2006- Korea 2017 IDB Invest 2016-2017 Luxembourg 2003-2017 IDB Special Fund 2009-2016 Netherlands 2003-2017 International Development Association 2003-2017 2 Li Z, et al. BMJ Global Health 2019; 4:e001614. doi: 10.1136/bmjgh-2019-001614 Supplementary material BMJ Global Health Appendix Table 2. List of donor countries included in the CRS (continued) DAC members Non-DAC multilateral donors Non-DAC donors Private donors International Fund for Agricultural New Zealand 2003-2017 Development 2003-2017 Norway 2003-2017 International Labour Organization 2012-2017 Poland 2013-2017 International Monetary Fund 2003-2017 Portugal 2003-2017 International Atomic Energy Agency 2015-2017 International Bank for Reconstruction and Slovak Republic 2013-2017 Development 2003-2017 Slovenia 2010-2017 International Finance Corporation 2012-2015 Spain 2003-2017 Islamic Development Bank 2003-2017 Sweden 2003-2017 Montreal Protocol 2015 Joint United Nations Programme on Switzerland 2003-2017 HIV/AIDS 2003-2017 United Kingdom 2003-2017 Nordic Development Fund 2009-2017 OPEC Fund for International United States 2003-2017 Development 2009-2017 Organization for Security and Co- operation in Europe 2010-2017 Swedish Postcode Lottery 2016-2017 United Nations Children's Fund 2003-2017 United Nations Development Programme 2004-2017 United Nations Peacebuilding Fund 2007-2017 United Nations Population Fund 2003-2017 United Nations Relief and Works Agency 2005-2017 World Food Programme 2008-2017 World Health Organization 2011-2017 3 Li Z, et al. BMJ Global Health 2019; 4:e001614. doi: 10.1136/bmjgh-2019-001614 Supplementary material BMJ Global Health Appendix Table 3. Keywords used to search for reproductive health projects, including HIV/ADIS, in the Creditor Reporting System Millenuim Development unprotected sexual abstinence copper IUD Hepatitis B transmission prevent youth pregnancy safe blood supply Goal 6 activity abstinent counselling and testing herpes transmission morning-after pill preventing HIV safe injection unsafe sex acquired immune highly active prevention of mother-to- CVR most at risk safe sex unwanted pregnancy deficiency syndrome antiretroviral therapy child transmission acquired immunno mother to child aids D&C hiv progestin-only pill safer sex unwanted sex deficiency syndrome transmission mother to child hiv aids aids dental dam hiv education progestogen hormone SDM urinate after sex transmission mother to child progestogen only aids education depo Provera injection HIV transmission sex worker urinate shortly after sex transmission injectables mother-to-child aids progestogen-only antiretroviral therapy diaphragm HIV/AIDS sexual assault urination after sex transmission contraceptive pill mother-to-child sexually transmissible ART dilation and curettage homosexual progestogen-only pills urination shortly after sex transmission infection sexually transmitted ARV drug regimens hormonal contraception multiple partners prostitute UTI disease sexually transmitted barrier method EC HPV transmission NFP protected sex vaginal ring infection human basal body temperature ECP oral contraceptive pill psychological service spermicide vasectomy immunodeficiency virus BBT emergency contraception implant outcourse psychological support STD vct BCC essential service infected children ovc psychosocial service sterilization vesectomy birth control estrogen infected person ovulation psychosocial support STI viral burden birth control pill family planning injectable contraceptives pain relief pull out method STM viral load 4 Li Z, et al. BMJ Global Health 2019; 4:e001614. doi: 10.1136/bmjgh-2019-001614 Supplementary material BMJ Global Health Appendix Table 3. Keywords used to search for reproductive health projects, including HIV/ADIS, in the Creditor Reporting System (continued) parent to child blood safety family size intra uterine device rape Sympto-Thermal Method viral titer transmission parent-to-child reduce adolescent voluntary counselling C virus FAMs IUD testing and counseling transmission pregnancies and testing reduce adolescent calendar method female condom lactational amenorrhea pee after sex testing and counselling withdrawal pregnancy cd4 count fertility awareness LAM pee shortly after sex reduce pregnancies the minipill people living with transmission of Hepatitis cervical cap fetile days LARC reduce pregnancy HIV/AIDS B reduce the transmission chlamydia fetile period levonorgestrel PEP transmission of herpes of hiv chronically ill forced sex levonorgestrel Plan B reduce youth pregnancies transmission of HIV long-acting reversible reducing the transmission CIC forced to sex PLHA transmission of HPV contraception of hiv clinical monitoring forcedsex make sex safer pmtct retroviral tubal ligation COCs gay male circumcision POPs retrovirale TwoDay method post-exposure coitus interruptus GFATM male condom retroviralen ulipristal acetate prophylaxis Global Fund to Fight prevent adolescent reverse transcriptase condom manual penetration UNAIDS AIDS pregnancies inhibitor prevent adolescent contraception gonorrhea material support rhythm method underage sex pregnancy contraceptive haart MDG6 prevent pregnancies risky sex unintended pregnancy contraceptive pill HBV microbicide prevent pregnancy risky sexual behavior unprotected sex Note: 1. We have translated all the keywords listed above to Spanish, French, Portuguese, Italian, Dutch, German, Norwegian, and Swedish 2. We performed keywords searching using 1) all lower case; 2) all upper case; 3) capitalize the first letter of each word 4) capitalize the first letter of the term 3. To prevent missing keywords containing unrecognizable characters (e.g. “c?ndom”), we replaced each letter of the keywords in the table with “?”, “??” “/” or spacing. 5 Li Z, et al. BMJ Global Health 2019; 4:e001614. doi: 10.1136/bmjgh-2019-001614 Supplementary material BMJ Global Health Appendix Table 3. Keywords used to search for reproductive health projects, including HIV/ADIS, in the Creditor Reporting System (continued) 4. Reference: a. Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2017 (GBD 2017) Results. [Internet]. Seattle, United States: Institute for Health Metrics and Evaluation (IHME). 2018 [cited 2018 Dec 19]. Available from: http://ghdx.healthdata.org/gbd-results-tool b. Dieleman JL, Schneider MT, Haakenstad A, Singh L, Sadat N, Birger M, et al. Development assistance for health: past trends, associations, and the future of international financial flows for health. Lancet. 2016 Jun;387(10037):2536–44. c. Dieleman JL, Graves CM, Templin T, Johnson E, Baral R, Leach-Kemon K, et al. Global Health Development Assistance Remained Steady In 2013 But Did Not Align With Recipients’ Disease Burden. Health Aff. 2014 May 2;33(5):878–86. d. Ravishankar N, Gubbins P, Cooley RJ, Leach-Kemon K, Michaud CM, Jamison DT, et al. Financing of global health: tracking development assistance for health from 1990 to 2007. Lancet. 2009
Load more

Recommended publications
  • Hypertrichosis Terminalis
    97297 Med Genet 1996;33:972-974 An autosomal dominant syndrome of acromegaloid facial appearance and generalised J Med Genet: first published as 10.1136/jmg.33.11.972 on 1 November 1996. Downloaded from Department of hypertrichosis terminalis Medical Genetics, Belfast City Hospital, Lisburn Road, Belfast BT9 7AB, Northern Ireland Alan D Irvine, Olivia M Dolan, David R Hadden, Fiona J Stewart, E Ann Bingham, A D Irvine Norman C Nevin F J Stewart N C Nevin Department of Dermatology, Royal Abstract A family with four affected subjects in three Group of Hospitals, Belfast BT12 6BA, We report a family in which a phenotype generations is reported. Affected subjects show Northern Ireland of acromegaloid facial appearance (AFA) a characteristic acromegaloid facial appearance 0 M Dolan and generalised hypertrichosis terminalis (AFA) and generalised hypertrichosis ter- E A Bingham segregates through three generations. minalis. The syndrome is inherited as an auto- Sir George E Clark Congenital hypertrichosis terminalis and somal dominant trait and appears to be fully Metabolic Unit, Royal AFA have been previously reported as in- penetrant. Acromegaloid facial appearance and Group of Hospitals, dependent autosomal dominant traits. hypertrichosis terminalis have been described Belfast BT12 6BA, Northern Ireland This is the first report to delineate an auto- in association with thickened oral mucosa and D R Hadden somal dominant transmission of the com- gingival hyperplasia.'"2 Affected patients in our Correspondence to: bined phenotype. family did not have intraoral lesions. The Dr Irvine. (JtMed Genet 1996;33:972-974) syndrome in our family appears to be discrete Received 14 May 1996 from the acromegaloid facial appearance syn- Revised version accepted for Key words: terminal hypertrichosis; acromegaloid drome,3 Gorlin-Chaudhry-Moss syndrome,4 publication 28 June 1996 facies; autosomal dominant.
    [Show full text]
  • Digital Clubbing
    Review Article Digital clubbing Malay Sarkar, D. M. Mahesh1, Irappa Madabhavi2 Department of Pulmonary Medicine, Indira Gandhi Medical College, Shimla, 1Department of Endocrinology, Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry, 2Post Graduate Student (Medicine), Indira Gandhi Medical College, Shimla, India ABSTRACT Digital clubbing is an ancient and important clinical signs in medicine. Although clubbed fingers are mostly asymptomatic, it often predicts the presence of some dreaded underlying diseases. Its exact pathogenesis is not known, but platelet‑derived growth factor and vascular endothelial growth factor are recently incriminated in its causation. The association of digital clubbing with various disease processes and its clinical implications are discussed in this review. KEY WORDS: Cancer, digital clubbing, hypertrophic osteoarthropathy, megakaryocytes, vascular endothelial growth factor Address for correspondence: Dr. Malay Sarkar, Department of Pulmonary Medicine, Indira Gandhi Medical College, Shimla ‑ 171 001, India. E‑mail: [email protected] INTRODUCTION long bones and occasional painful joint enlargement. It was initially known as hypertrophic pulmonary Digital clubbing is characterized by a focal bulbous osteoarthropathy (HPOA) based on the fact that majority enlargement of the terminal segments of the fingers of cases of HOA are due to malignant thoracic tumors. and/or toes due to proliferation of connective tissue The term “pulmonary” was later abandoned as it was between nail matrix and the distal phalanx. It results in realized that the skeletal syndrome may occur in several increase in both anteroposterior and lateral diameter of non‑pulmonary diseases and even may occur without the nails.[1] Clubbed fingers are also known as watch‑glass any underlying illness.
    [Show full text]
  • Steatocystoma-Multiplex.Pdf
    Steatocystoma multiplex Description Steatocystoma multiplex is a skin disorder characterized by the development of multiple noncancerous (benign) cysts known as steatocystomas. These growths begin in the skin's sebaceous glands, which normally produce an oily substance called sebum that lubricates the skin and hair. Steatocystomas are filled with sebum. In affected individuals, steatocystomas typically first appear during adolescence and are found most often on the torso, neck, upper arms, and upper legs. These cysts are usually the only sign of the condition. However, some affected individuals also have mild abnormalities involving the teeth or the fingernails and toenails. Frequency Although the prevalence of steatocystoma multiplex is unknown, it appears to be rare. Causes Steatocystoma multiplex can be caused by mutations in the KRT17 gene. This gene provides instructions for making a protein called keratin 17, which is produced in the nails, the hair follicles, and the skin on the palms of the hands and soles of the feet. It is also found in the skin's sebaceous glands. Keratin 17 partners with a similar protein called keratin 6b to form networks that provide strength and resilience to the skin, nails, and other tissues. The KRT17 gene mutations that cause steatocystoma multiplex alter the structure of keratin 17, preventing it from forming strong, stable networks within cells. The defective keratin network disrupts the growth and function of cells in the skin and nails, including cells that make up the sebaceous glands. These abnormalities lead to the growth of sebum-containing cysts in people with steatocystoma multiplex. However, it is unclear why steatocystomas are typically the only feature of this disorder.
    [Show full text]
  • Therapeutic Use of Botulinum Neurotoxins in Dermatology: Systematic Review
    toxins Review Therapeutic Use of Botulinum Neurotoxins in Dermatology: Systematic Review Emanuela Martina †, Federico Diotallevi †, Giulia Radi †, Anna Campanati * and Annamaria Offidani Dermatological Clinic, Department of Clinical and Molecular Sciences, Polytechnic Marche University, 60020 Ancona, Italy; [email protected] (E.M.); [email protected] (F.D.); [email protected] (G.R.); annamaria.offi[email protected] (A.O.) * Correspondence: [email protected] † These authors equally contributed to the manuscript. Abstract: Botulinum toxin is a superfamily of neurotoxins produced by the bacterium Clostridium Botulinum with well-established efficacy and safety profile in focal idiopathic hyperhidrosis. Recently, botulinum toxins have also been used in many other skin diseases, in off label regimen. The objective of this manuscript is to review and analyze the main therapeutic applications of botulinum toxins in skin diseases. A systematic review of the published data was conducted, following Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. Botulinum toxins present several label and off-label indications of interest for dermatologists. The best-reported evidence concerns focal idiopathic hyperhidrosis, Raynaud phenomenon, suppurative hidradenitis, Hailey–Hailey disease, epidermolysis bullosa simplex Weber–Cockayne type, Darier’s disease, pachyonychia congenita, aquagenic keratoderma, alopecia, psoriasis, notalgia paresthetica, facial erythema and flushing, and oily skin.
    [Show full text]
  • Pachydermoperiostosis in a Patient with Crohn's Disease: Treatment
    IJMS Vol 43, No 1, January 2018 Case Report Pachydermoperiostosis in a Patient with Crohn’s Disease: Treatment and Literature Review Maryam Mobini1, MD; Abstract Ozra Akha1, MD; Hafez Fakheri2, MD; Pachydermoperiostosis (PDP) is a rare disorder characterized Hadi Majidi3, MD; by pachydermia, digital clubbing, periostitis, and an excess Sanam Fattahi4, MD of affected males. It is the primary form of hypertrophic osteoarthropathy (HOA) and there are some rare associations of PDP with other disorders. Here we describe a patient with 1Department of Internal Medicine, Diabetes Research Center, Faculty of Crohn’s disease associated with PDP. A 26-year-old man, who Medicine, Mazandaran University of was a known case of Crohn’s disease, referred with diffuse Medical Sciences, Sari, Iran; 2Department of Gastroenterology, swelling in the upper and lower limbs and cutis verticis gyrata Inflammatory Gut and Liver Research since 7 years ago. PDP was suspected and endocrinological Center, Mazandaran University of and radiological studies were conducted for the evaluation Medical Sciences, Sari, Iran; 3Department of Radiology, Orthopedic of underlying disease. He was prescribed celecoxib, low- Research Center, Faculty of Medicine, dose prednisolone, and pamidronate to control the swelling, Mazandaran University of Medical periostitis, azathiopurine, and mesalazine according to Sciences, Sari, Iran; 4Medical Student, Faculty of Medicine, gastrointestinal involvement. In conclusion, it is important to Mazandaran University of Medical identify this condition since a misdiagnosis might subject the Sciences, Sari, Iran patient to unnecessary investigations. Correspondence: Maryam Mobini, MD; Please cite this article as: Mobini M, Akha O, Fakheri H, Majidi H, Fattahi S. Imam Khomeini Hospital, Pachydermoperiostosis in a Patient with Crohn’s Disease: Treatment and Razi Street, Sari, Iran Literature Review.
    [Show full text]
  • Steatocystoma Multiplex-A Rare Genetic Disorder: a Case Report and Review of the Literature Pathology Section
    Case Report DOI: 10.7860/JCDR/2012/4691.2698 Steatocystoma Multiplex-A Rare Genetic Disorder: A Case Report and Review of the Literature Pathology Section HEMLATA T. KAMRA, PRADEEP A. GADGIL, AJAY G. OVHAL, RAHUL R. NARKHEDE ABSTRACT is asymptomatic, is a cosmetic threat to the patient . Only a A 17 years old female presented with multiple asymptomatic few cases of the patients with an autosomal dominant mutation, cutaneous cysts all over body, sparing the head and neck who had keratin 17, have been reported. We are reporting here, region. The microscopic examination of the cysts showed the a case of steatocystoma multiplex in a 17 years old female, features of steatocystoma multiplex. This disorder, although it along with its review of literature. Key Words: Steatocystoma, Autosomal dominant, Radiofrequency probe INTRODUCTION On examination, the dermal cysts were found to be round to oval, Steatocystoma multiplex is a rare genetic disorder with an well defined and smooth surfaced, without a punctum and to vary autosomal dominant type of inheritance which usually presents in in diameter from 2-5mm [Table/Fig-1]. The patient gave a history adolescence or is sporadic in nature. Rare cases with an autosomal of similar lesions in her father too. The systemic and the laboratory dominant pattern of inheritance have been published till now [1]. findings were normal. Sonography revealed multiple nodules The disease presents with multiple asymptomatic cysts on the which were oval in shape, which were relatively well marginated axilla, groin, trunk, scrotum and the proximal extremities because and hypoechoic and with a posterior enhancement.
    [Show full text]
  • Coexistence of Hidradenitis Suppurativa and Steatocystoma Multiplex
    Original Article Journal of Cutaneous Medicine and Surgery 00(0) 1–5 Coexistence of Hidradenitis Suppurativa © The Author(s) 2021 and Steatocystoma Multiplex; Is It a New Article reuse guidelines: Variant of Hidradenitis Suppurativa? sagepub. com/ journals- permissions DOI: 10. 1177/ 1203 4754 2110 10145 journals. sagepub. com/ home/ cms 1 2 Joshua Fletcher , Claudia Posso- De Los Rios , 3 4 Jadranka Jambrosic , and Afsaneh Alavi Abstract Hidradenitis suppurativa and steatocystoma multiplex may coexist in the same patient. The overlap of these 2 conditions could be suggestive of an unrecognized defect in follicular proliferation mutual in the pathogenesis of both conditions. Here we present 5 patients with both hidradenitis suppurativa and steatocystoma multiplex. Recognizing the overlap between these 2 conditions is important for accurate diagnosis, management, and identification of potential surgical candidates, as well as future basic science research. Keywords dermatology, inflammatory dermatoses Introduction its natural history, mimicking both hidradenitis suppura- tiva and acne conglobata.4,10 Hidradenitis suppurative (HS) is a chronic, inflammatory, The overlap of HS and SM, or SMS, could be sugges- recurrent disease affecting the folliculopilosebaceous unit tive of an unrecognized defect in follicular proliferation in the apocrine gland-bearing areas. This leads to comedo- common to both diseases or a mutual genetic link. 1 nes, nodules, abscesses, sinus tracts, and scarring. HS Recognizing this overlap is important for an accurate usually presents in a sporadic or familial fashion, but rare diagnosis, management and identification of potential sur- syndromic forms recognizable for their unique symptom- gical candidates, as well as future basic science research. 2 atology have been described in the literature.
    [Show full text]
  • Pili Torti: a Feature of Numerous Congenital and Acquired Conditions
    Journal of Clinical Medicine Review Pili Torti: A Feature of Numerous Congenital and Acquired Conditions Aleksandra Hoffmann 1 , Anna Wa´skiel-Burnat 1,*, Jakub Z˙ ółkiewicz 1 , Leszek Blicharz 1, Adriana Rakowska 1, Mohamad Goldust 2 , Małgorzata Olszewska 1 and Lidia Rudnicka 1 1 Department of Dermatology, Medical University of Warsaw, Koszykowa 82A, 02-008 Warsaw, Poland; [email protected] (A.H.); [email protected] (J.Z.);˙ [email protected] (L.B.); [email protected] (A.R.); [email protected] (M.O.); [email protected] (L.R.) 2 Department of Dermatology, University Medical Center of the Johannes Gutenberg University, 55122 Mainz, Germany; [email protected] * Correspondence: [email protected]; Tel.: +48-22-5021-324; Fax: +48-22-824-2200 Abstract: Pili torti is a rare condition characterized by the presence of the hair shaft, which is flattened at irregular intervals and twisted 180◦ along its long axis. It is a form of hair shaft disorder with increased fragility. The condition is classified into inherited and acquired. Inherited forms may be either isolated or associated with numerous genetic diseases or syndromes (e.g., Menkes disease, Björnstad syndrome, Netherton syndrome, and Bazex-Dupré-Christol syndrome). Moreover, pili torti may be a feature of various ectodermal dysplasias (such as Rapp-Hodgkin syndrome and Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome). Acquired pili torti was described in numerous forms of alopecia (e.g., lichen planopilaris, discoid lupus erythematosus, dissecting Citation: Hoffmann, A.; cellulitis, folliculitis decalvans, alopecia areata) as well as neoplastic and systemic diseases (such Wa´skiel-Burnat,A.; Zółkiewicz,˙ J.; as cutaneous T-cell lymphoma, scalp metastasis of breast cancer, anorexia nervosa, malnutrition, Blicharz, L.; Rakowska, A.; Goldust, M.; Olszewska, M.; Rudnicka, L.
    [Show full text]
  • Pachydermoperiostosis (Touraine–Solente–Gole Syndrome): a Case
    Joshi et al. Journal of Medical Case Reports (2019) 13:39 https://doi.org/10.1186/s13256-018-1961-z CASE REPORT Open Access Pachydermoperiostosis (Touraine–Solente– Gole syndrome): a case report Amir Joshi1* , Gaurav Nepal1, Yow Ka Shing2, Hari Prasad Panthi1 and Suman Baral1 Abstract Background: Pachydermoperiostosis (PDP) is a rare disorder characterized by clubbing of the fingers, thickening of the skin (pachyderma), and excessive sweating (hyperhidrosis). It typically appears during childhood or adolescence, often around the time of puberty, and progresses slowly. Clinical presentations of PDP can be confused with secondary hypertrophic osteoarthropathy, psoriatic arthritis, rheumatoid arthritis, thyroid acropachy, and acromegaly. Case presentation: A Mongolian male, aged 19 years, resident of a hilly district of Nepal, with history of consanguinity, presented to our outpatient department with chief complaints of pain and swelling in both hands and feet for 6 years. The pain was insidious in onset, throbbing in nature, and not relieved by over-the-counter medications. The patient also complained of profuse sweating, progressive enlargement of hands and feet, and gradual coarsening of facial features. On examination there were marked skin folds in the forehead, face, and eyelids. Clubbing and swelling of bilateral knee joints and ankle joints was also evident. He was subsequently investigated extensively for acromegaly. Insulin-like growth factor-1 level and oral glucose tolerance test were normal. Radiography of various bones showed
    [Show full text]
  • Dermatological Indications for the Use of Isotretinoin Beyond Acne
    Journal of Dermatological Treatment ISSN: 0954-6634 (Print) 1471-1753 (Online) Journal homepage: https://www.tandfonline.com/loi/ijdt20 Dermatological indications for the use of isotretinoin beyond acne Emily Forbat, Faisal R. Ali & Firas Al-Niaimi To cite this article: Emily Forbat, Faisal R. Ali & Firas Al-Niaimi (2018) Dermatological indications for the use of isotretinoin beyond acne, Journal of Dermatological Treatment, 29:7, 698-705, DOI: 10.1080/09546634.2018.1445194 To link to this article: https://doi.org/10.1080/09546634.2018.1445194 Accepted author version posted online: 26 Feb 2018. Published online: 14 Mar 2018. Submit your article to this journal Article views: 503 View related articles View Crossmark data Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=ijdt20 JOURNAL OF DERMATOLOGICAL TREATMENT 2018, VOL. 29, NO. 7, 698–705 https://doi.org/10.1080/09546634.2018.1445194 REVIEW ARTICLE Dermatological indications for the use of isotretinoin beyond acne Emily Forbata, Faisal R. Alib and Firas Al-Niaimib aChelsea and Westminster Hospital, London, UK; bDermatological Surgery & Laser Unit, St John’s Institute of Dermatology, Guy’s Cancer Centre, Guy’s and St Thomas’ NHS Foundation Trust, London, UK ABSTRACT ARTICLE HISTORY While the use of isotretinoin has revolutionized the treatment of acne vulgaris, isotretinoin is increasingly Received 3 February 2018 recognized as a useful therapeutic option for many other cutaneous conditions. We review the evidence Accepted 14 February 2018 underlying the use of isotretinoin for a variety of dermatological indications including hidradenitis suppu- KEYWORDS rativa, sebaceous gland pathology, rosacea, scarring alopecia, cosmetic dermatology, and non-melanoma skin cancer prophylaxis amongst other uses, and thus consider alternative uses within dermatology prac- Isotretinoin; retinoids; rosacea; cosmetic tice.
    [Show full text]
  • Steatocystoma Multiplex Presenting As Acral Subcutaneous Nodules
    374 Letters to the Editor Steatocystoma Multiplex Presenting as Acral Subcutaneous Nodules Teruki Yanagi and Tetsuri Matsumura Department of Dermatology, Tonan Hospital N1W6, Chuo-ku, Sapporo 060-0001, Japan. E-mail: [email protected] Accepted March 20, 2006. Sir, We describe here a case of steatocystoma multiplex presenting as acral subcutaneous nodules. This case is unique due to: (i) acral distribution and (ii) presentation as subcutaneous nodules. As far as we know, there have been only 2 reports of steatocystoma multiplex (SM) occurring in a predominantly acral distribution. CASE REPORT A 47-year-old Japanese housewife was referred to our hospital with asymptomatic subcutaneous nodules on her forearms. She first noticed the subcutaneous nodules 10 years previously, and they had gradually increased in both size and number. They were not as- Fig. 2. Histopathological features. Well-encapsulated subcutaneous cysts with sociated with any pain or tenderness. Her family history infolded walls lined by stratified squamous epithelium without a granular and past clinical history were unremarkable. Physical layer (haematoxylin-eosin (H&E) stain; original magnification, ×10). Inset examination revealed multiple, mobile, well-defined, shows sebaceous gland lobules within the cyst wall. (H&E stain; original elastic-hard, 5–10 mm subcutaneous nodules on the magnification,× 100). flexor surface of the forearms; 8 on the right and 3 on the left (Fig. 1). There were no other lesions except for DISCUSSION the forearms and no nail changes. Clinically, the lesions were initially thought to be multiple lipomas and an This case of SM is unique due to (i) its acral distribu- excisional biopsy was performed to confirm the sus- tion and (ii) presentation as subcutaneous nodules.
    [Show full text]
  • Eruptive Vellus Hair Cysts: Report of a Pediatric Case with Partial Response to Calcipotriene Therapy
    PEDIATRIC DERMATOLOGY Series Editor: Camila K. Janniger, MD Eruptive Vellus Hair Cysts: Report of a Pediatric Case With Partial Response to Calcipotriene Therapy Emel Erkek, MD; Gülcan Saylam Kurtipek, MD; Deniz Duman, MD; Cihat ¸Sanli, MD; Sibel Erdo ˘gan, MD Eruptive vellus hair cysts (EVHCs) are character- the chest and abdomen (Figure 1). Histopathologic ized by asymptomatic, follicular, comedonelike examination of a punch biopsy specimen revealed papules usually located on the anterior chest and an oval cystic structure in the superficial dermis abdomen. We present a pediatric case of EVHC lined with a thin, stratified, squamous epithelium associated with attention deficit hyperactivity of 2 to 3 layers (Figure 2). The cyst wall was noted disorder that partially responded to calcipotriene to include a granular layer at focal areas. The cyst cream within 2 months. Our aim is to refamiliarize lumen contained lamellate keratin flakes and non- clinicians with a common albeit frequently unrec- pigmented vellus-type hairs (Figure 3). In serial ognized disorder of vellus hair follicles. sections, there was no evidence of sebaceous glands Cutis. 2009;84:295-298. within the cyst wall. The patient was diagnosed with EVHC, and twice daily calcipotriene cream 0.005% was pre- ruptive vellus hair cysts (EVHCs) were initially scribed for the lesions. At the end of the second described by Esterly et al1 in 1977. Although the month of follow-up, a partial response was attained, E disorder is relatively common, it rarely has been with complete resolution of some cysts and flatten- reported in the literature. ing of the remaining lesions (Figure 4).
    [Show full text]